Stock Price
32.25
Daily Change
-0.15 -0.46%
Monthly
-8.07%
Yearly
13.28%
Q2 Forecast
29.11

Veracyte reported $2.54B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Agilent USD 37.86B 3.64B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Bruker USD 7.16B 2.23B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
Laboratory Of America USD 20.8B 3.03B Dec/2025
Myriad Genetics USD 575M 98M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 191.32B 7.96B Dec/2025
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Waters USD 22.61B 5.25B Dec/2025